Company Filing History:
3 out of 204 
1 out of 987 
Years Active: 2018-2025
Title: Victor May: Innovator in Neurological Treatments
Introduction
Victor May is a notable inventor based in Essex, Vermont, who has made significant contributions to the field of neurological research. With a total of 3 patents, his work focuses on developing innovative solutions for treating various neurological diseases and disorders.
Latest Patents
One of Victor May's latest patents is titled "Small molecule antagonist to PACAP receptor and uses thereof." This invention relates to compounds that effectively block PACAP receptors, such as PAC1, and outlines methods for treating neurological diseases or disorders using these compounds. The conditions addressed include stress-related diseases like chronic stress, post-traumatic stress disorder (PTSD), anxiety, and general anxiety disorder. Additionally, it covers pain-related diseases, including chronic pain and migraines, as well as addiction to substances such as cocaine, alcohol, and opioids.
Another significant patent is focused on "Diagnostic and therapeutic methods and products related to anxiety disorders." This disclosure provides methods for diagnosing and treating anxiety disorders specifically in female subjects. The diagnosis and treatment are based on analyzing pituitary adenylate cyclase-activating polypeptide (PACAP) expression levels in tissue collected from these subjects.
Career Highlights
Victor May has worked with esteemed institutions, including the University of Vermont and State Agricultural College and Emory University. His research has contributed to advancing the understanding and treatment of neurological conditions.
Collaborations
Throughout his career, Victor has collaborated with notable professionals in the field, including Kerry J Ressler and Sayamwong E Hammack. These collaborations have further enriched his research and innovations.
Conclusion
Victor May's work exemplifies the impact of innovative research in the treatment of neurological disorders. His patents and collaborations highlight his commitment to improving the lives of individuals affected by these conditions.